Verve Therapeutics, Inc. (VERV)
USD 5.09
(-9.27%)
USD 5.09
(-9.27%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 11.75 Million | 1.94 Million | - | - | - |
| Cost of Revenue | 184.94 Million | 6.71 Million | 3.37 Million | 1.32 Million | 106 Thousand |
| Gross Profit | -173.18 Million | -4.77 Million | -3.37 Million | -1.32 Million | -106 Thousand |
| Operating Expenses | 234.88 Million | 167.62 Million | 87.06 Million | 40.62 Million | 13.64 Million |
| Selling, General and Administrative Expenses | 49.93 Million | 37.53 Million | 18.86 Million | 5.25 Million | 2.49 Million |
| Research and Development Expenses | 184.94 Million | 130.09 Million | 68.2 Million | 35.37 Million | 11.14 Million |
| Other Expenses | - | 1.48 Million | -33.38 Million | -5.23 Million | -5.93 Million |
| Cost and Expenses | 234.88 Million | 167.62 Million | 87.06 Million | 40.62 Million | 13.64 Million |
| Operating Income | -223.12 Million | -165.68 Million | -87.06 Million | -40.62 Million | -13.64 Million |
| Interest Expense | - | - | - | - | - |
| Income Tax Expense | 275 Thousand | 53 Thousand | -1.67 Million | -162 Thousand | -278 Thousand |
| Earnings before Tax | -199.79 Million | -157.33 Million | -120.31 Million | -45.7 Million | -19.29 Million |
| Net Income | -200.06 Million | -157.38 Million | -118.63 Million | -45.54 Million | -19.01 Million |
| Earnings Per Share Basic | -3.12 | -2.91 | -2.45 | -0.94 | -0.39 |
| Earnings Per Share Diluted | -3.12 | -2.91 | -2.45 | -0.94 | -0.39 |
| Weighted Average Shares Outstanding | 64.17 Million | 54.02 Million | 48.51 Million | 48.21 Million | 48.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 64.17 Million | 54.02 Million | 48.51 Million | 48.21 Million | 48.21 Million |
| Gross Margin | -14.73 | -2.46 | - | - | - |
| EBIT Margin | -18.51 | -83.92 | - | - | - |
| Profit Margin | -17.02 | -81.09 | - | - | - |
| EBITDA | -217.66 Million | -162.88 Million | -85.53 Million | -39.29 Million | -13.53 Million |
| Earnings Before Tax Margin | -18.98 | -85.36 | - | - | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 6.86 Million | 6.69 Million | 5.69 Million | 5.14 Million | 11.75 Million | 3.11 Million |
| Cost of Revenue | 1.75 Million | 1.66 Million | 1.63 Million | 1.51 Million | 5.45 Million | 3.19 Million |
| Gross Profit | 5.11 Million | 5.02 Million | 4.06 Million | 3.62 Million | 6.3 Million | -82 Thousand |
| Operating Expenses | 63.77 Million | 63.86 Million | 60.9 Million | 57.57 Million | 229.42 Million | 55.45 Million |
| Selling, General and Administrative Expenses | 13.83 Million | 12.88 Million | 12.53 Million | 10.76 Million | - | 11.68 Million |
| Research and Development Expenses | 49.93 Million | 50.98 Million | 48.37 Million | 46.81 Million | - | 43.76 Million |
| Other Expenses | - | 1.67 Million | 78 Thousand | -713 Thousand | 165 Thousand | 802 Thousand |
| Cost and Expenses | 63.77 Million | 65.53 Million | 62.53 Million | 59.09 Million | 234.88 Million | 55.45 Million |
| Operating Income | -56.91 Million | -58.83 Million | -56.84 Million | -53.94 Million | -223.12 Million | -52.33 Million |
| Interest Expense | - | - | - | 6.28 Million | - | - |
| Income Tax Expense | -104 Thousand | 66 Thousand | 106 Thousand | 32 Thousand | 275 Thousand | -67 Thousand |
| Earnings before Tax | -50.02 Million | -49.73 Million | -48.63 Million | -48.32 Million | -199.79 Million | -45.69 Million |
| Net Income | -50.13 Million | -49.8 Million | -48.73 Million | -48.35 Million | -200.06 Million | -45.75 Million |
| Earnings Per Share Basic | -0.60 | -0.59 | -0.59 | -0.69 | - | -0.72 |
| Earnings Per Share Diluted | -0.60 | -0.59 | -0.59 | -0.69 | - | -0.72 |
| Weighted Average Shares Outstanding | 84.22 Million | 84.22 Million | 83.13 Million | 69.67 Million | 64.17 Million | 63.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 84.22 Million | 84.22 Million | 83.13 Million | 69.67 Million | 64.17 Million | 63.21 Million |
| Gross Margin | 0.74 | 0.75 | 0.71 | 0.71 | 0.54 | -0.03 |
| EBIT Margin | -8.29 | -8.54 | -9.69 | -10.19 | - | -16.79 |
| Profit Margin | -7.30 | -7.44 | -8.56 | -9.40 | -17.02 | -14.68 |
| EBITDA | -56.91 Million | -57.17 Million | -55.21 Million | -52.43 Million | - | -52.33 Million |
| Earnings Before Tax Margin | -8.29 | -8.79 | -9.98 | -10.49 | -18.98 | -16.79 |
5027
0379
5303
PURPLE
MAXX
DNDPF